High-risk, non-muscle-invasive bladder cancer is defined as any transitional ... This high-risk group includes patients with high-grade papillary stage Ta or T1 tumors and any patient with ...

A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...

Bladder cancer is characterized by the high rates of recurrence ... higher in Ta disease than in T1 disease (50 vs 30%). The rates are also affected by tumor grade, with 50% in G1 disease ...

"We were particularly pleased to see that these results are further supported by an exploratory sub-analysis including only ...

Discover how a TB vaccine could revolutionise bladder cancer treatment. Find out more about this groundbreaking study.

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.

Professors Rik Bryan and Nicholas James explain how an image-directed pathway for muscle-invasive bladder cancer improves ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

Artificial intelligence (AI)-based histologic assays identify nonmuscle-invasive bladder ... 944 cases of high-risk NMIBC, high-grade Ta was diagnosed in 34.1%, high-grade T1 in 54.8%, carcinoma ...